Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/primary-central-nervous-system-lymphoma-update-and-current-approach-VzBLXlQh5t
References (33)
-
D. Villa, J. Connors, T. Shenkier, R. Gascoyne, L. Sehn, K. Savage (2010)
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy.Annals of oncology : official journal of the European Society for Medical Oncology, 21 5
-
M. Deckert, A. Engert, W. Brück, A. Ferreri, J. Finke, G. Illerhaus, W. Klapper, A. Korfel, R. Küppers, M. Maarouf, M. Montesinos-Rongen, W. Paulus, U. Schlegel, H. Lassmann, Otmar Wiestler, R. Siebert, L. Deangelis (2011)
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphomaLeukemia, 25
-
B. Kasenda, E. Schorb, K. Fritsch, J. Finke, G. Illerhaus (2015)
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.Annals of oncology : official journal of the European Society for Medical Oncology, 26 3
-
A. Juergens, H. Pels, S. Rogowski, K. Fliessbach, A. Glasmacher, A. Engert, M. Reiser, V. Diehl, M. Vogt-Schaden, G. Egerer, G. Schackert, H. Reichmann, F. Kroschinsky, U. Bode, U. Herrlinger, M. Linnebank, M. Deckert, R. Fimmers, I. Schmidt-Wolf, U. Schlegel (2010)
Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphomaAnnals of Neurology, 67
-
E. Thiel, A. Korfel, P. Martus, L. Kanz, F. Griesinger, M. Rauch, A. Röth, B. Hertenstein, Theda Toll, T. Hundsberger, H. Mergenthaler, M. Leithäuser, T. Birnbaum, L. Fischer, K. Jahnke, U. Herrlinger, L. Plasswilm, T. Nägele, T. Pietsch, M. Bamberg, M. Weller (2010)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.The Lancet. Oncology, 11 11
-
K. Fritsch, B. Kasenda, C. Hader, G. Nikkhah, M. Prinz, V. Haug, S. Haug, G. Ihorst, J. Finke, G. Illerhaus (2011)
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.Annals of oncology : official journal of the European Society for Medical Oncology, 22 9
-
H. Pels, A. Juergens, A. Glasmacher, H. Schulz, A. Engert, M. Linnebank, G. Schackert, H. Reichmann, F. Kroschinsky, M. Vogt-Schaden, G. Egerer, U. Bode, C. Schaller, M. Lamprecht, P. Hau, M. Deckert, R. Fimmers, C. Bangard, I. Schmidt-Wolf, U. Schlegel (2009)
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II studyJournal of Neuro-Oncology, 91
-
A. Ferreri, M. Reni, M. Foppoli, M. Martelli, Gerasimus Pangalis, M. Frezzato, M. Cabras, A. Fabbri, G. Corazzelli, F. Ilariucci, G. Rossi, R. Soffietti, C. Stelitano, D. Vallisa, F. Zaja, L. Zoppegno, G. Aondio, G. Avvisati, M. Balzarotti, A. Brandes, José Fajardo, H. Gomez, A. Guarini, G. Pinotti, L. Rigacci, Catrina Uhlmann, P. Picozzi, P. Vezzulli, M. Ponzoni, E. Zucca, F. Caligaris‐cappio, F. Cavalli (2009)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trialThe Lancet, 374
-
J. Villano, M. Koshy, M. Koshy, H. Shaikh, T. Dolecek, B. McCarthy (2011)
Age, gender, and racial differences in incidence and survival in primary CNS lymphomaBritish Journal of Cancer, 105
-
L. Abrey, T. Batchelor, A. Ferreri, M. Gospodarowicz, E. Pulczynski, E. Zucca, Justin Smith, A. Korfel, C. Soussain, L. Deangelis, E. Neuwelt, B. O'neill, E. Thiel, T. Shenkier, F. Graus, M. Bent, J. Seymour, P. Poortmans, J. Armitage, F. Cavalli (2005)
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 22
-
J. Latz, Karen Schneck, K. Nakagawa, M. Miller, C. Takimoto (2009)
Population Pharmacokinetic/Pharmacodynamic Analyses of Pemetrexed and Neutropenia: Effect of Vitamin Supplementation and Differences between Japanese and Western PatientsClinical Cancer Research, 15
-
Kai Miller, Taylor Abel, A. Hebb, Jeffrey Ojemann (2011)
Reorganization of large-scale physiology in hand motor cortex following hemispheric strokeNeurology, 76
-
A. Omuro, L. Taillandier, O. Chinot, M. Rio, C. Carnin, M. Barrié, C. Soussain, M. Tanguy, S. Choquet, V. Leblond, K. Hoang-Xuan, .. OnbehalfoftheANOCEFGroup (2011)
Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?Journal of Neuro-Oncology, 104
-
Jay-Jiguang Zhu, E. Gerstner, D. Engler, M. Mrugala, W. Nugent, Kristin Nierenberg, F. Hochberg, R. Betensky, T. Batchelor (2009)
High-dose methotrexate for elderly patients with primary CNS lymphoma.Neuro-oncology, 11 2
-
E. Bessell, A. López-Guillermo, S. Villà, E. Verger, B. Nomdedeu, J. Petit, P. Byrne, E. Montserrat, F. Graus (2002)
Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 1
-
A. Ferreri, M. Reni, F. Pasini, A. Calderoni, U. Tirelli, A. Pivnik, G. Aondio, F. Ferrarese, H. Gómez, M. Ponzoni, B. Borisch, F. Berger, C. Chassagne, P. Iuzzolino, A. Carbone, J. Weis, E. Pedrinis, T. Motta, A. Jouvet, T. Barbui, F. Cavalli, J. Blay (2002)
A multicenter study of treatment of primary CNS lymphomaNeurology, 58
-
U. Hegde, A. Filie, R. Little, J. Janik, N. Grant, S. Steinberg, K. Dunleavy, E. Jaffe, A. Abati, M. Stetler-Stevenson, W. Wilson (2005)
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.Blood, 105 2
-
DE Ney, AS Reiner, KS Panageas, HS Brown, LM Deangelis, LE Abrey (2010)
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experienceCancer, 116
-
R. Schroers, A. Baraniskin, C. Heute, M. Vorgerd, A. Brunn, Jan Kuhnhenn, A. Kowoll, A. Alekseyev, W. Schmiegel, U. Schlegel, M. Deckert, H. Pels (2010)
Diagnosis of leptomeningeal disease in diffuse large B‐cell lymphomas of the central nervous system by flow cytometry and cytopathologyEuropean Journal of Haematology, 85
-
A. Ferreri, G. Licata, M. Foppoli, G. Corazzelli, E. Zucca, C. Stelitano, F. Zaja, S. Fava, R. Paolini, A. Franzin, L. Politi, M. Ponzoni, M. Reni (2011)
Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.The oncologist, 16 3
-
A. Gonzalez-Aguilar, J. Soto-Hernández (2011)
The management of primary central nervous system lymphoma related to AIDS in the HAART eraCurrent Opinion in Oncology, 23
-
O. Abla, S. Weitzman, J. Blay, B. O'neill, L. Abrey, E. Neuwelt, N. Doolittle, J. Baehring, K. Pradhan, S. Martin, M. Guerrera, Shafqat Shah, H. Ghesquières, Michael Silver, R. Betensky, T. Batchelor (2011)
Primary CNS Lymphoma in Children and Adolescents: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)Clinical Cancer Research, 17
-
R. Khan, W. Shi, H. Thaler, L. Deangelis, L. Abrey (2002)
Is Intrathecal Methotrexate Necessary in the Treatment of Primary CNS Lymphoma?Journal of Neuro-Oncology, 58
-
D. Ney, A. Reiner, K. Panageas, Hayley Brown, L. Deangelis, L. Abrey (2010)
Characteristics and outcomes of elderly patients with primary central nervous system lymphomaCancer, 116
-
P. Morris, L. Abrey (2009)
Therapeutic challenges in primary CNS lymphomaThe Lancet Neurology, 8
-
G. Shah, J. Yahalom, D. Correa, R. Lai, J. Raizer, D. Schiff, R. Larocca, B. Grant, L. Deangelis, L. Abrey (2007)
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 30
-
G. Vassal, D. Valteau, M. Bonnay, C. Patte, F. Aubier, J. Lemerle (1990)
Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma.Pediatric hematology and oncology, 7 1
-
S. Bayraktar, U. Bayraktar, J. Ramos, A. Stefanovic, I. Lossos (2010)
Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factorsJournal of Neuro-Oncology, 101
-
N. Mohile, L. Deangelis, L. Abrey (2008)
The utility of body FDG PET in staging primary central nervous system lymphoma.Neuro-oncology, 10 2
-
A. Omuro, L. Taillandier, O. Chinot, C. Carnin, M. Barrié, K. Hoang-Xuan (2007)
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderlyJournal of Neuro-Oncology, 85
-
TT Batchelor, SA Grossman, T Mikkelsen (2011)
Rituximab monotherapy for patients with recurrent primary CNS lymphomaNeurology., 76
-
C. Soussain, K. Hoang-Xuan, L. Taillandier, E. Fourme, S. Choquet, F. Witz, O. Casasnovas, B. Dupriez, B. Souleau, A. Taksin, C. Gisselbrecht, A. Jaccard, A. Omuro, M. Sanson, M. Janvier, B. Kolb, J. Zini, V. Leblond (2008)
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 15
-
M. Wieduwilt, Francisco Valles, S. Issa, C. Behler, James Hwang, M. McDermott, P. Treseler, J. O'Brien, M. Shuman, S. Cha, L. Damon, J. Rubenstein (2012)
Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRIClinical Cancer Research, 18
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by Springer-Verlag Wien
- Subject
- Medicine & Public Health; Oncology; Medicine/Public Health, general
- ISSN
- 1865-5041
- eISSN
- 1865-5076
- DOI
- 10.1007/s12254-012-0045-9
- Publisher site
- See Article on Publisher Site
Abstract
Primary central nervous system lymphoma (PCNSL) is a rare type of lymphoma that requires a specialised approach to management. An initial evaluation should determine the extent of disease within the CNS compartment and must exclude the presence of systemic lymphoma. Methotrexate (MTX)-based chemotherapy is the standard of care but questions remain about the optimal drugs for use in conjunction with MTX as well as the best approach to consolidation. Furthermore, several special populations may require a modified approach to therapy.
Journal
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 18, 2012